ZVRA

NASDAQ HEALTHCARE

Zevra Therapeutics Inc.

$9.70

-$0.08 (-0.82%)

Live quote

52w: $7.16 – $15.04

Loading chart…

P/E Ratio6.95

P/B Ratio2.81

EV/EBITDA—

Debt/Equity—

ROE40.44%

ROIC—

Revenue Growth350.91%

Gross Margin—

Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.

Own ZVRA? Track it here.

Create a free account to add ZVRA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account